Michael Yellin

4PUBLICATIONS
82CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 07, 2026
IL10R Inhibition Induces Neutrophil Tumoricidal Activity.

Danny N Khalil, Ricardo Gomez, Amit Regev

|Sep 08, 2025
CD27 Agonist Antibodies Mediate Clinical Responses through Intratumoral Stimulation in B-cell Malignancies: Multicenter RiVa Trial.

Lara E Buermann, Louise Stanton, Matthew J J Rose-Zerilli

|Feb 18, 2025
Clinical and Translational Results from PORTER, a Multicohort Phase I Platform Trial of Combination Immunotherapy in Metastatic Castration-Resistant Prostate Cancer.

Matthew D Galsky, Karen A Autio, Christopher R Cabanski

|Aug 08, 2022
Safety, tolerability and efficacy of agonist anti-CD27 antibody (varlilumab) administered in combination with anti-PD-1 (nivolumab) in advanced solid tumors.

Rachel E Sanborn, Michael J Pishvaian, Margaret K Callahan

Pageof 1

Frequent Collaborators

3 joint publications

Tibor Keler

2 joint publications

Christopher R Cabanski

1 joint publications

Matthew D Galsky

1 joint publications

Karen A Autio